Precera Bioscience Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $6.93M
Latest Deal Amount
  • Investors
  • 1

Precera Bioscience General Information

Description

Provider of quantitative medication detection technology designed to improve individual and population health. The company's medication detection technology helps with actionable data regarding medication therapy plans and to execute those plans through clinical analytics to optimize medication therapy, enabling physicians to identify potentially harmful drug interactions.

Contact Information

Website
www.precera.com
Formerly Known As
Paracelsus CIP LLC
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Laboratory Services (Healthcare)
Primary Office
  • CoolSpring Life Sciences Center
  • 393 Nichol Mill Lane, Suite 34
  • Franklin, TN 37067
  • United States
+1 (615) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Precera Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 17-Nov-2017 $6.93M 00.000 000.00 Completed Generating Revenue
To view Precera Bioscience’s complete valuation and funding history, request access »

Precera Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Precera Bioscience’s complete cap table history, request access »

Precera Bioscience Executive Team (8)

Name Title Board Seat Contact Info
Pamela Weir President, Chief Executive Officer & Board Mmeber
Scott Daniels Ph.D Chief Scientific Officer
Murray Blackshear Founder & Chairman
You’re viewing 3 of 8 executive team members. Get the full list »

Precera Bioscience Board Members (7)

Name Representing Role Since
James Burns Self Board Member 000 0000
Jeff Patton MD Precera Bioscience Board Member 000 0000
Jeff Rothenberger Self Board Member 000 0000
Murray Blackshear Precera Bioscience Founder & Chairman 000 0000
Scott Heubner Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Precera Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precera Bioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NueCura Partners Angel Group Minority 000 0000 000000 0
To view Precera Bioscience’s complete investors history, request access »